Biography and Research Information
OverviewAI-generated summary
Nancy Green is a Professor at the University of Arkansas for Medical Sciences. Her research has focused on several key areas, including maternal and perinatal health, with publications examining changes in gestational age distribution and the impact on preterm birth rates, as well as the cost of hospitalization for preterm and low birth weight infants. Green has also investigated the neurological development risks associated with late preterm births.
Beyond perinatal health, Green's scholarly work has extended to conservation biology, with publications addressing species' adaptive capacity to climate change and improving conservation outcomes through new research paradigms. Her earlier work also includes studies on gender stereotypes in human-computer interaction. Green's research network includes collaborators such as Michele Cottler-Fox, Mayumi Nakagawa, Gina Drobena, and H. McAloon, all affiliated with the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.
With a highly cited designation, Green's academic contributions are reflected in her h-index of 41 and over 7,700 citations across 442 publications. She remains an active researcher, with recent publications indicating continued engagement in her fields of study.
Metrics
- h-index: 41
- Publications: 442
- Citations: 7,719
Positions
-
ProfessorColumbia University Pediatrics ORCID
-
ProfessorUniversity of Arkansas for Medical Sciences ORCID
Selected Publications
-
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025)
-
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)
Collaboration Network
Top Collaborators
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
Similar Researchers
Based on overlapping research topics